Background & Aims Over the last decade, clinical experiences and research studies raised
concerns regarding use of proton pump inhibitors (PPIs) as part of the diagnostic strategy for …

Eosinophilic esophagitis (EoE) is an eosinophil-rich, TH 2 antigen–mediated disease of
increasing pediatric and adult worldwide prevalence. Diagnosis requires greater than or …

Consensus diagnostic recommendations to distinguish GORD from eosinophilic
oesophagitis (EoE) by response to a trial of proton pump inhibitors (PPIs) unexpectedly …

Objectives: Eosinophilic esophagitis (EoE) represents a chronic, immune/antigen-mediated
esophageal disease characterized clinically by symptoms related to esophageal dysfunction …

Background & Aims Despite the growing recognition of duodenal alterations in the
pathophysiology of functional dyspepsia (FD), the effect and mechanism of proton pump …

Eosinophilic esophagitis (EoE) is a chronic immune/antigen-mediated clinicopathologic
condition that has become an increasingly important cause of upper gastrointestinal …

Background Esophageal eosinophilia can be proton pump inhibitor (PPI) resistant or
responsive, representing 2 entities known as eosinophilic esophagitis (EoE) and PPI …

Summary Background Proton pump inhibitors (PPIs) are the most commonly used first‐line
therapy for patients with eosinophilic oesophagitis (EoE). However, many aspects related to …

Abstract Background Eosinophilic esophagitis (EoE) is a chronic immune-mediated rare
disease, characterized by esophageal dysfunctions. It is likely to be primarily activated by …

Eosinophilic esophagitis (EoE) is a chronic immune-mediated disease of the esophagus
characterized clinically by symptoms related to esophageal dysfunction and histologically by …